Search research articles
Contact Us
Filters
Showing results (21-30 of 55) with videos related to
Page
of 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 4, 2007
Phase II trial of ixabepilone, an epothilone B analog, in patients with metastatic breast cancer previously untreated with taxanes
Neelima Denduluri, Jennifer A Low, James J Lee, et al.
Nature Cancer
|
June 8, 2026
First-line durvalumab in combination with trastuzumab deruxtecan in women with locally advanced unresectable or metastatic, hormone-receptor-negative, HER2-low breast cancer: multicenter, open-label, phase 1b/2 BEGONIA platform trial
Peter Schmid, Seock-Ah Im, Zbigniew Nowecki, et al.
Clinical Breast Cancer
|
September 19, 2019
Relationship Between Hereditary Cancer Syndromes and Oncotype DX Recurrence Score
Nicole Casasanta, Sarit T Kipnis, Laura Linville, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2006
Influence of garlic (Allium sativum) on the pharmacokinetics of docetaxel
Michael C Cox, Jennifer Low, James Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2016
Selection of Optimal Adjuvant Chemotherapy Regimens for Human Epidermal Growth Factor Receptor 2 (HER2) -Negative and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline Adaptation of the Cancer Care Ontario Clinical Practice Guideline
Neelima Denduluri, Mark R Somerfield, Andrea Eisen, et al.
Journal of Genetic Counseling
|
October 3, 2020
BRCA1/2 mutations and risk-reducing bilateral salpingo-oophorectomy among Latinas: The UPTAKE study
Filipa Lynce, Ilana Schlam, Xue Geng, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 11, 2015
Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices
Neelima Denduluri, Debra A Patt, Yunfei Wang, et al.
Seminars in Oncology
|
December 17, 2013
Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know?
Jeanne S Mandelblatt, Arti Hurria, Brenna C McDonald, et al.
Breast Cancer Research : BCR
|
February 11, 2017
Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR<sup>+</sup>, HER2<sup>-</sup> breast cancer that had progressed during or after prior endocrine therapy
Antonino Musolino, Mario Campone, Patrick Neven, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 7, 2016
Innovations in American Society of Clinical Oncology Practice Guideline Development
Mark R Somerfield, Kari Bohlke, George P Browman, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 55) with videos related to
Sort By:
Page
of 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 4, 2007
Phase II trial of ixabepilone, an epothilone B analog, in patients with metastatic breast cancer previously untreated with taxanes
Neelima Denduluri, Jennifer A Low, James J Lee, et al.
Nature Cancer
|
June 8, 2026
First-line durvalumab in combination with trastuzumab deruxtecan in women with locally advanced unresectable or metastatic, hormone-receptor-negative, HER2-low breast cancer: multicenter, open-label, phase 1b/2 BEGONIA platform trial
Peter Schmid, Seock-Ah Im, Zbigniew Nowecki, et al.
Clinical Breast Cancer
|
September 19, 2019
Relationship Between Hereditary Cancer Syndromes and Oncotype DX Recurrence Score
Nicole Casasanta, Sarit T Kipnis, Laura Linville, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2006
Influence of garlic (Allium sativum) on the pharmacokinetics of docetaxel
Michael C Cox, Jennifer Low, James Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2016
Selection of Optimal Adjuvant Chemotherapy Regimens for Human Epidermal Growth Factor Receptor 2 (HER2) -Negative and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline Adaptation of the Cancer Care Ontario Clinical Practice Guideline
Neelima Denduluri, Mark R Somerfield, Andrea Eisen, et al.
Journal of Genetic Counseling
|
October 3, 2020
BRCA1/2 mutations and risk-reducing bilateral salpingo-oophorectomy among Latinas: The UPTAKE study
Filipa Lynce, Ilana Schlam, Xue Geng, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 11, 2015
Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices
Neelima Denduluri, Debra A Patt, Yunfei Wang, et al.
Seminars in Oncology
|
December 17, 2013
Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know?
Jeanne S Mandelblatt, Arti Hurria, Brenna C McDonald, et al.
Breast Cancer Research : BCR
|
February 11, 2017
Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR<sup>+</sup>, HER2<sup>-</sup> breast cancer that had progressed during or after prior endocrine therapy
Antonino Musolino, Mario Campone, Patrick Neven, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 7, 2016
Innovations in American Society of Clinical Oncology Practice Guideline Development
Mark R Somerfield, Kari Bohlke, George P Browman, et al.
Page
of 6